Logo image of SBC

SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SBC - US73245B1070 - Common Stock

3.57 USD
-0.07 (-1.92%)
Last: 11/28/2025, 8:00:04 PM
Fundamental Rating

5

Overall SBC gets a fundamental rating of 5 out of 10. We evaluated SBC against 101 industry peers in the Health Care Providers & Services industry. SBC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SBC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year SBC was profitable.
In the past year SBC has reported a negative cash flow from operations.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

With an excellent Return On Assets value of 10.57%, SBC belongs to the best of the industry, outperforming 95.05% of the companies in the same industry.
With an excellent Return On Equity value of 13.63%, SBC belongs to the best of the industry, outperforming 81.19% of the companies in the same industry.
SBC's Return On Invested Capital of 22.45% is amongst the best of the industry. SBC outperforms 95.05% of its industry peers.
Industry RankSector Rank
ROA 10.57%
ROE 13.63%
ROIC 22.45%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

SBC's Profit Margin of 17.71% is amongst the best of the industry. SBC outperforms 100.00% of its industry peers.
SBC's Operating Margin of 38.45% is amongst the best of the industry. SBC outperforms 100.00% of its industry peers.
The Gross Margin of SBC (76.97%) is better than 90.10% of its industry peers.
Industry RankSector Rank
OM 38.45%
PM (TTM) 17.71%
GM 76.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SBC is creating value.
Compared to 1 year ago, SBC has less shares outstanding
SBC has a better debt/assets ratio than last year.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

SBC has an Altman-Z score of 6.10. This indicates that SBC is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.10, SBC belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
SBC has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
SBC has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. SBC outperforms 81.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 6.1
ROIC/WACC2.59
WACC8.67%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.98 indicates that SBC has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.98, SBC belongs to the best of the industry, outperforming 92.08% of the companies in the same industry.
SBC has a Quick Ratio of 3.95. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.95, SBC belongs to the best of the industry, outperforming 93.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.95
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.06% over the past year.
The Revenue has grown by 74.40% in the past year. This is a very strong growth!
EPS 1Y (TTM)39.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.01%
Revenue 1Y (TTM)74.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.35%

3.2 Future

The Earnings Per Share is expected to decrease by -2.00% on average over the next years.
SBC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.61% yearly.
EPS Next Y-27.17%
EPS Next 2Y-10.18%
EPS Next 3Y-2%
EPS Next 5YN/A
Revenue Next Year-16.5%
Revenue Next 2Y-6.13%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.93, which indicates a rather cheap valuation of SBC.
Based on the Price/Earnings ratio, SBC is valued cheaply inside the industry as 96.04% of the companies are valued more expensively.
SBC is valuated cheaply when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.36, the valuation of SBC can be described as very cheap.
SBC's Price/Forward Earnings ratio is rather cheap when compared to the industry. SBC is cheaper than 96.04% of the companies in the same industry.
SBC is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.93
Fwd PE 7.36
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 98.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.97
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

A cheap valuation may be justified as SBC's earnings are expected to decrease with -2.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.18%
EPS Next 3Y-2%

More info and screens

0

5. Dividend

5.1 Amount

SBC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (11/28/2025, 8:00:04 PM)

3.57

-0.07 (-1.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14 2025-11-14/bmo
Earnings (Next)03-26 2026-03-26
Inst Owners0.62%
Inst Owner ChangeN/A
Ins Owners89.24%
Ins Owner Change0%
Market Cap366.21M
Revenue(TTM)188.19M
Net Income(TTM)33.33M
Analysts80
Price Target8.33 (133.33%)
Short Float %0.87%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.84%
Min EPS beat(2)-85.33%
Max EPS beat(2)89.02%
EPS beat(4)2
Avg EPS beat(4)-21.1%
Min EPS beat(4)-98.74%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.51%
Min Revenue beat(2)-9.04%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.89%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.38%
PT rev (3m)25.64%
EPS NQ rev (1m)-5.72%
EPS NQ rev (3m)-12%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.52%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-2.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.22%
Valuation
Industry RankSector Rank
PE 7.93
Fwd PE 7.36
P/S 1.95
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 1.54
EV/EBITDA 2.97
EPS(TTM)0.45
EY12.61%
EPS(NY)0.48
Fwd EY13.58%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.83
BVpS2.38
TBVpS2.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.91
Profitability
Industry RankSector Rank
ROA 10.57%
ROE 13.63%
ROCE 28.42%
ROIC 22.45%
ROICexc 56.12%
ROICexgc 60%
OM 38.45%
PM (TTM) 17.71%
GM 76.97%
FCFM N/A
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.1
Cap/Depr 96.72%
Cap/Sales 1.65%
Interest Coverage 980.59
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.95
Altman-Z 6.1
F-Score5
WACC8.67%
ROIC/WACC2.59
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.01%
EPS Next Y-27.17%
EPS Next 2Y-10.18%
EPS Next 3Y-2%
EPS Next 5YN/A
Revenue 1Y (TTM)74.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.35%
Revenue Next Year-16.5%
Revenue Next 2Y-6.13%
Revenue Next 3Y-0.61%
Revenue Next 5YN/A
EBIT growth 1Y42.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-567.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-391.7%
OCF growth 3YN/A
OCF growth 5YN/A

SBC MEDICAL GROUP HOLDINGS I / SBC FAQ

What is the fundamental rating for SBC stock?

ChartMill assigns a fundamental rating of 5 / 10 to SBC.


What is the valuation status for SBC stock?

ChartMill assigns a valuation rating of 6 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Fairly Valued.


How profitable is SBC MEDICAL GROUP HOLDINGS I (SBC) stock?

SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 5 / 10.


Can you provide the financial health for SBC stock?

The financial health rating of SBC MEDICAL GROUP HOLDINGS I (SBC) is 7 / 10.


What is the expected EPS growth for SBC MEDICAL GROUP HOLDINGS I (SBC) stock?

The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -27.17% in the next year.